|
|
|
Insider
Information: |
Alton Gregg H |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
61,846 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,803,960 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
61,846 |
|
|
Total
Value |
$3,803,960 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NVAX |
Novavax Inc |
Director |
|
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,100 |
3,800 |
0 |
- |
|
NVAX |
Novavax Inc |
Director |
|
2022-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
700 |
700 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Patient Officer |
|
2019-02-15 |
4 |
A |
$57.45 |
$18,959 |
D/D |
330 |
58,046 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2019-02-06 |
4 |
D |
$68.75 |
$402,944 |
D/D |
(5,861) |
57,716 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
19,151 |
63,577 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-03-01 |
4 |
AS |
$77.64 |
$1,967,315 |
D/D |
(25,000) |
44,426 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-03-01 |
4 |
OE |
$40.56 |
$699,660 |
D/D |
17,250 |
69,426 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-21 |
4 |
D |
$80.69 |
$475,587 |
D/D |
(5,894) |
52,176 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
19,992 |
58,070 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-20 |
4 |
S |
$81.54 |
$1,176,992 |
I/I |
(14,435) |
0 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
38,078 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-01 |
4 |
OE |
$40.56 |
$699,660 |
D/D |
17,250 |
62,738 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
|
2018-02-01 |
4 |
AS |
$83.29 |
$2,087,860 |
D/D |
(25,000) |
37,738 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2018-01-11 |
4 |
AS |
$79.00 |
$2,370,000 |
D/D |
(30,000) |
45,488 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2018-01-11 |
4 |
OE |
$24.91 |
$932,062 |
D/D |
25,875 |
75,488 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2018-01-02 |
4 |
AS |
$72.34 |
$1,108,019 |
D/D |
(15,000) |
49,613 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2018-01-02 |
4 |
OE |
$24.91 |
$214,806 |
D/D |
8,625 |
64,613 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-12-01 |
4 |
OE |
$24.91 |
$214,806 |
D/D |
8,625 |
70,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-12-01 |
4 |
AS |
$74.46 |
$1,119,552 |
D/D |
(15,000) |
55,988 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-11-01 |
4 |
AS |
$74.74 |
$1,122,285 |
D/D |
(15,000) |
62,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-11-01 |
4 |
OE |
$24.91 |
$214,806 |
D/D |
8,625 |
77,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-10-02 |
4 |
AS |
$81.84 |
$2,066,307 |
D/D |
(25,000) |
68,738 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-10-02 |
4 |
OE |
$24.91 |
$429,611 |
D/D |
17,250 |
93,738 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-09-01 |
4 |
OE |
$24.91 |
$429,611 |
D/D |
17,250 |
101,488 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
|
2017-09-01 |
4 |
AS |
$82.96 |
$2,076,188 |
D/D |
(25,000) |
76,488 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|